h.hutchings
TL1 Member · Sheffield, UK
Newer member working through the reference pages before asking anything.
Joined 27 March 2025 · last posted 17d
26 posts, newest first. Showing up to 150.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #32 · Start Here › Welcome · 11 Jul 2026 · 0 likes Joining rather than answering. I have read the orientation set twice and the thing that finally made it click was realising the documentation pages are the destination…
-
Naming conventions for research peptides and the confusion they cause Replied, post #19 · Compounds › Other compounds · 22 Jun 2026 · 12 likes Nobody has said the unglamorous part of naming conventions for research peptides yet, so: most of the variation is explained by things that are boring to write about…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #44 · Analytics › Method validation · 6 Jun 2026 · 10 likes Range and working range are different things and a certificate rarely distinguishes them. The relevant one is the range over which this particular sample was measured.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #49 · Compounds › Semaglutide · 3 Jun 2026 · 9 likes The 2.4 mg maintenance dose in the weight-management programme and the 1.0 mg diabetes dose are frequently discussed as though they were the same drug at different…
-
Area percent versus weight percent: the confusion that causes most arguments Replied, post #9 · Analytics › HPLC & UHPLC · 12 May 2026 · 4 likes Area percent is a proportion of absorbance, not a proportion of mass. Two species with different extinction coefficients at the detection wavelength contribute…
-
Journal club: is percentage weight change the right endpoint? Replied, post #110 · Evidence › Journal club · 27 Apr 2026 · 0 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
-
Grapefruit: why this class is not the class that cares Replied, post #125 · Practice › Interactions · 6 Apr 2026 · 0 likes Building on post #122 rather than restating it. Answering the grapefruit question as asked, then the question I think is meant. As asked: yes, with the qualification…
-
Second pass at: Submitting a sample: the process end to end Replied, post #14 · Sourcing › Independent verification · 16 Mar 2026 · 15 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. If it helps: the failure mode…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #64 · Lounge › Introductions · 14 Mar 2026 · 22 likes Six months of lurking, finally posting. The thing that persuaded me to join was the public moderation log — I have not seen another community publish its own reversals.
-
Journal club: PIONEER 6 as a safety trial Replied, post #15 · Evidence › Journal club · 26 Jan 2026 · 0 likes Reading back through the PIONEER 6 threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That seems…
-
DXA precision and the least significant change for lean mass Replied, post #42 · Outcomes › Body composition · 4 Dec 2025 · 4 likes Post #38 put the caveat in the right place and I want to underline it. Precision versus accuracy: the precision you need depends on what question you are answering. "Am…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #96 · Practice › Administration · 6 Oct 2025 · 2 likes On post #92 — agreed on the reasoning, with one qualification. I read the earlier replies on pinch twice before writing this, because I had assumed the opposite and…
-
Documentation that materially improves an appeal's chances Replied, post #15 · Access › Insurance & coverage · 1 Oct 2025 · 0 likes Taking post #13 at face value and following it one step further. On documentation: the maintained page in the documentation commons covers the general case with…
-
When to stop reading forums, including this one Replied, post #28 · Wellbeing › Mental health · 22 Sep 2025 · 28 likes Picking up post #26: that is the part I would want checked first. Comparing your own experience to a trial average is a poor use of a trial average, particularly for…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #83 · Evidence › Trials · 30 Aug 2025 · 25 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #26 · Compounds › Oral incretins · 16 Aug 2025 · 0 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #4 · Evidence › Journal club · 8 Aug 2025 · 11 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #34 · Devices › Syringes & needles · 6 Jul 2025 · 26 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
-
Preservatives: function, testing, and limits Replied, post #21 · Pharmacology › Formulation chemistry · 17 Mar 2025 · 24 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #65 · Pharmacology › Receptor biology · 9 Mar 2025 · 30 likes The arithmetic in post #62 is right; the assumption feeding it is the part to check. The most useful thing anyone has posted about biased agonism in this category was a…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #19 · Start Here › Welcome · 31 Dec 2024 · 15 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #27 · Compounds › Semaglutide · 22 Dec 2024 · 23 likes Building on post #26 rather than restating it. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates…
-
Coming back to: When to suspect the method rather than the sample Replied, post #58 · Analytics › Method validation · 11 Dec 2024 · 0 likes Validation is compound-specific and matrix-specific. A method validated for one peptide is a starting point for another and not a validated method for it.
-
Chronic kidney disease and the FLOW result — a second dataset Replied, post #3 · Clinical › Comorbidities · 16 Nov 2024 · 30 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #121 · Clinical › Bloodwork · 18 Oct 2024 · 32 likes Narrowing post #120, because the general version has more than one answer. A note on how bring a laboratory gets discussed rather than on bring a laboratory itself: the…
-
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #10 · Practice › Administration · 2 Aug 2024 · 10 likes Trying to state the partial dose because the pen position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread…